TY  - GEN
AU  - Kim,Hwi Young
AU  - Park,Joong-Won
AU  - Nam,Byung-Ho
AU  - Kim,Hyun Keun
AU  - Choi,Joon-Il
AU  - Kim,Tae Hyun
AU  - Kim,Hyun Beom
AU  - Kim,Chang-Min
TI  - Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatments
SN  - 1440-1746
PY  - 2012///0213
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Benzenesulfonates
KW  - Carcinoma, Hepatocellular
KW  - blood
KW  - Chi-Square Distribution
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Liver Neoplasms
KW  - Logistic Models
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Invasiveness
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Patient Selection
KW  - Phenylurea Compounds
KW  - Propensity Score
KW  - Proportional Hazards Models
KW  - Protein Kinase Inhibitors
KW  - Pyridines
KW  - Republic of Korea
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Risk Factors
KW  - Sorafenib
KW  - Survival Rate
KW  - Time Factors
KW  - Treatment Outcome
KW  - alpha-Fetoproteins
KW  - analysis
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1440-1746.2011.06751.x
ER  -